Table 3.2: Overall survival (OS) and cumulative mortality rates (CMR) for both competing risks concerning therapy group EBRT.
Years |
OS |
CMR tumor specific (95%CI) |
CMR Comorbidity specific (95%CI) |
2 |
97.7 |
0.6 (0.0 - 1.4) |
1.7 (0.50 - 2.8) |
4 |
94.6 |
1.6 (0.4 - 2.7) |
3.8 (2.0 - 5.6) |
6 |
92.2 |
2.1 (0.7 - 3.5) |
5.7 (3.5 - 8.0) |
8 |
88.2 |
3.4 (1.5 - 5.2) |
8.4 (5.6 - 11.3) |
10 |
84.3 |
4.2 (2.0 - 6.3) |
11.6 (8.0 - 15.2) |
12 |
81.1 |
6.0 (3.1 - 9.0) |
12.8 (8.9 - 16.8) |
14 |
76.1 |
9.3 (5.0 - 13.5) |
14.6 (10.0 - 19.2) |
16 |
69.0 |
11.4 (6.3 - 16.4) |
19.6 (13.5 - 25.7) |
18 |
61.7 |
13.7 (7.0 - 20.5) |
24.6 (16.6 - 32.5) |
20 |
56.8 |
16.2 (8.1 - 24.4) |
27.1 (18.0 - 36.1) |